Orange Juice and Glycaemic Control in Type 2 Diabetes Mellitus

  • STATUS
    Recruiting
  • participants needed
    18
  • sponsor
    Hasselt University
Send
Updated on 19 February 2024
See if I qualify
plasma glucose

Summary

The evidence on the consumption of 100% orange juice in people with type 2 diabetes is highly variable and largely out-of-date, with a few studies reporting acute negative glycaemic effects when 100% orange juice is drunk with or without a meal. The aim of the project is to study the impact of the intake of a single serving of 100% orange juice on glycaemic control in male patients with pre-existing type 2 diabetes mellitus. In addition, immunological parameters and Alzheimer disease related biomarkers will be assessed to examine the chronic inflammatory state of these patients

Details
Condition NIDDM, diabetes mellitus, type 2, diabetes mellitus, type 2
Age 25-65 years
Treatment orange juice concentrate, Sugar-sweetened orange-flavoured beverage, Whole orange juice with skin removed
Clinical Study IdentifierNCT04412798
SponsorHasselt University
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Inclusion Criteria: Male individuals (aged 25-65 years) with up to 8 years of T2DM, according to ADA criteria (Two-hour plasma glucose 200 mg/dL (11.1 mmol/L) during OGTT. The test should be performed as described by the WHO, using a glucose load containing the equivalent of 75-g anhydrous glucose dissolved in water; or HbA1c > 6.5% (48 mmol/mol))

Exclusion Criteria

participants on exogenous insulin therapy
HbA1c >8.5%
BMI <27 or >33 kg/m
regular smokers (>1 cigarette per day)
participants with established cardiovascular disease
neurological disease
cancer
renal disease
Participants who are unwilling to consume any of the standard foods/drinks
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

plasma glucose

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name
Edit Delete

Added by • 

 • 

Private

Edit Delete

Reply by • • Private
Edit Delete

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.